Call Options

29 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.01 - $6.7 $1.05 Million - $1.41 Million
210,200 Added 29.31%
927,400 $5.82 Million
Q2 2024

Aug 15, 2024

SELL
$4.05 - $5.43 $795,420 - $1.07 Million
-196,400 Reduced 21.5%
717,200 $3.74 Million
Q1 2024

May 07, 2024

BUY
$3.25 - $5.27 $2.4 Million - $3.89 Million
737,500 Added 418.8%
913,600 $4.14 Million
Q4 2023

Feb 14, 2024

SELL
$3.34 - $4.29 $1.12 Million - $1.44 Million
-336,800 Reduced 65.67%
176,100 $641,000
Q3 2023

Nov 14, 2023

BUY
$3.91 - $5.45 $1.25 Million - $1.74 Million
318,800 Added 164.25%
512,900 $2.12 Million
Q2 2023

Aug 11, 2023

BUY
$3.72 - $4.79 $39,432 - $50,774
10,600 Added 5.78%
194,100 $789,000
Q1 2023

May 16, 2023

SELL
$3.95 - $5.63 $650,565 - $927,261
-164,700 Reduced 47.3%
183,500 $752,000
Q4 2022

Feb 14, 2023

SELL
$3.02 - $5.37 $103,284 - $183,654
-34,200 Reduced 8.94%
348,200 $1.84 Million
Q3 2022

Nov 14, 2022

SELL
$2.99 - $4.35 $547,469 - $796,484
-183,100 Reduced 32.38%
382,400 $1.18 Million
Q2 2022

Aug 15, 2022

BUY
$2.67 - $4.77 $538,005 - $961,154
201,500 Added 55.36%
565,500 $2.16 Million
Q1 2022

May 16, 2022

BUY
$2.62 - $4.45 $55,806 - $94,785
21,300 Added 6.22%
364,000 $1.34 Million
Q4 2021

Feb 14, 2022

SELL
$4.05 - $5.37 $1.48 Million - $1.97 Million
-366,300 Reduced 51.66%
342,700 $1.5 Million
Q3 2021

Nov 15, 2021

BUY
$3.89 - $5.48 $140,040 - $197,280
36,000 Added 5.35%
709,000 $3.08 Million
Q2 2021

Aug 11, 2021

BUY
$3.61 - $5.45 $1.01 Million - $1.53 Million
280,500 Added 71.46%
673,000 $3.67 Million
Q1 2021

May 17, 2021

SELL
$3.14 - $6.14 $341,946 - $668,646
-108,900 Reduced 21.72%
392,500 $1.54 Million
Q4 2020

Feb 16, 2021

SELL
$1.79 - $4.04 $5,728 - $12,928
-3,200 Reduced 0.63%
501,400 $1.57 Million
Q3 2020

Nov 16, 2020

BUY
$1.56 - $2.08 $589,368 - $785,824
377,800 Added 297.95%
504,600 $949,000
Q2 2020

Aug 14, 2020

SELL
$0.94 - $2.21 $43,992 - $103,428
-46,800 Reduced 26.96%
126,800 $222,000
Q1 2020

May 15, 2020

SELL
$0.84 - $1.76 $451,500 - $946,000
-537,500 Reduced 75.59%
173,600 $179,000
Q4 2019

Feb 14, 2020

BUY
$1.14 - $1.49 $119,357 - $156,003
104,700 Added 17.27%
711,100 $917,000
Q3 2019

Nov 14, 2019

SELL
$1.04 - $1.44 $322,920 - $447,120
-310,500 Reduced 33.86%
606,400 $758,000
Q2 2019

Aug 14, 2019

BUY
$1.09 - $1.88 $40,330 - $69,560
37,000 Added 4.21%
916,900 $1.05 Million
Q1 2019

May 15, 2019

SELL
$1.14 - $2.25 $52,097 - $102,825
-45,700 Reduced 4.94%
879,900 $1.73 Million
Q4 2018

Feb 14, 2019

SELL
$1.02 - $2.05 $165,852 - $333,330
-162,600 Reduced 14.94%
925,600 $981,000
Q3 2018

Nov 14, 2018

BUY
$1.01 - $2.19 $35,451 - $76,869
35,100 Added 3.33%
1,088,200 $1.99 Million
Q2 2018

Aug 14, 2018

BUY
$1.59 - $2.38 $50,085 - $74,970
31,500 Added 3.08%
1,053,100 $2 Million
Q1 2018

May 15, 2018

BUY
$2.28 - $3.8 $168,720 - $281,200
74,000 Added 7.81%
1,021,600 $2.33 Million
Q4 2017

Feb 14, 2018

SELL
$2.28 - $6.71 $2.08 Million - $6.11 Million
-910,800 Reduced 49.01%
947,600 $2.2 Million
Q3 2017

Nov 14, 2017

BUY
$1.15 - $2.29 $2.14 Million - $4.26 Million
1,858,400
1,858,400 $4.03 Million

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.59B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.